Journal of Korean Academy of Fundamentals of Nursing (기본간호학회지)

Korean Academy of Fundamentals of Nursing (기본간호학회)
권호 표지
DOI QR코드

DOI QR Code

Chemotherapy Induced Peripheral Neuropathy, Sleep and Quality of Life among Patients with Gastric Cancer Receiving Chemotherapy

항암화학요법을 받는 위암 환자의 말초신경병증, 수면 및 삶의 질에 대한 연구

  • Kim, Hyemi (National Cancer Center.Graduate School of Clinical Health Sciences, Ewha Womans University) ;
  • Park, Hyojung (College of Nursing.Ewha Research Institute of Nursing Science, Ewha Womans University)
  • 김혜미 (국립암센터 간호사.이화여자대학교 임상보건융합대학원) ;
  • 박효정 (이화여자대학교 간호대학.이화간호과학연구소)
  • Received : 2018.04.09
  • Accepted : 2018.07.13
  • Published : 2018.08.31
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: Purpose of this study was to investigate relationships and influence of peripheral neuropathy, sleep, and quality of life in patients with gastric cancer who are receiving chemotherapy. Methods: Participants were 131 patients with gastric cancer being treated at a chemotherapy outpatient clinic and receiving chemotherapy. Data were analyzed using descriptive statistics, t-test, ANOVA, and multiple regression analysis with the SPSS program. Results: Mean score for peripheral neuropathy was 24.66, for sleep, 6.71 and for quality of life, 67.69. Peripheral neuropathy had a significant positive correlation with sleep (r=.26, p=.003) and sleep had a significant negative correlation with quality of life (r=-.50, p<.001). The regression model explaining quality of patients'lives was significant (F=11.91, p<.001), peripheral neuropathy, sleep, and pain due to anticancer drugs and number ofneurotoxic anticancer drugs explained 25.1% of the variance in quality of life and sleep was the most important factor. Conclusion: To improve the quality of life for these patients, individualized nursing interventions for pain should be provided according to number of anticancer drugs in the chemotherapy. Also there is a need to identify ways to assess peripheral neuropathy and sleep disorders that are appropriate in the treatment and reduce side effects during treatment.

Keywords

References

  1. National Cancer Information Center. Statistics of cancer [Internet]. Gyeonggido: National Cancer Information Center; 2016 [cited 2017 November 15]. Available from: https://www.cancer.go.kr/lay1/S1T639C641/contents.do
  2. Seretny M, Currie GL, Sena ES, Ramnarine S, Grant R, MacLeod MR, et al. Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis. Pain. 2014;155(12):2461-2470. https://doi.org/ 10.1016/j.pain.2014.09.020
  3. Hong JS, Tian J, Wu LH. The influence of chemotherapy-induced neurotoxicity on psychological distress and sleep disturbance in cancer patients. Current Oncology. 2014;21(4):174-180. https://doi.org/10.3747/co.21.1984
  4. Hershman DL, Lacchetti C, Dworkin RH, Lavoie Smith EM, Bleeker J, Cavaletti G, et al. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American society of clinical oncology clinical practice guideline. Journal of Clinical Oncology. 2014;32(18):1941-1967. https://doi.org/10.1200/JCO.2013.54.0914
  5. Kim KY, Lee SH, Kim JH, Oh PJ. Disturbance in ADL from chemotherapy-induced peripheral neuropathy and quality of life in cancer patients: The mediating effect of psychological distress. Journal of Korean Academy of Nursing. 2015;45(5):661-670. https://doi.org/10.4040/jkan.2015.45.5.661
  6. Kim JH, Lee KM, Jeon MJ, Seol ME, Lee SH, Park J. Symptom and interference of activities of daily living of chemotherapy-induced peripheral neuropathy in patients receiving taxanes and platinums. Asian Oncology Nursing. 2013;13(3):145-151. https://doi.org/10.5388/aon.2013.13.3.145
  7. Mols F, Beijers T, Lemmens V, van den Hurk CJ, Vreugdenhil G, van de Poll-Franse LV. Chemotherapy-induced neuropathy and its association with quality of life among 2-to 11-year colorectal cancer survivors: Results from the population-based profiles registry. Journal of Clinical Oncology. 2013;31(21):2699-2707. https://doi.org/10.1200/JCO.2013.49.1514
  8. Cleeland CS, Zhao F, Chang VT, Sloan JA, O'Mara AM, Gilman PB, et al. The symptom burden of cancer: Evidence for a core set of cancer-related and treatment-related symptoms from the eastern cooperative oncology group symptom outcomes and practice patterns study. Cancer. 2013;119(24):4333-4340. https://doi.org/10.1002/cncr.28376
  9. Kim GD, Jang HJ. Effects of pain, sleep disturbance, and fatigue on the quality of life in patients with pancreatic cancer undergoing chemotherapy. Asian Oncology Nursing. 2012;12(2):117-124. https://doi.org/10.5388/aon.2012.12.2.117
  10. Tofthagen C, Donovan KA, Morgan MA, Shibata D, Yeh Y. Oxaliplatin-induced peripheral neuropathy's effects on health-related quality of life of colorectal cancer survivors. Supportive Care in Cancer. 2013;21(12):3307-3313. https://doi.org/10.1007/s00520-013-1905-5
  11. Ancoli-Israel S. Sleep disturbances in cancer: A review. Sleep Medicine Research. 2015;6(2):45-49. https://doi.org/10.17241/smr.2015.6.2.45
  12. Innominato PF, Spiegel D, Ulusakarya A, Giacchetti S, Bjarnason GA, Levi F, et al. Subjective sleep and overall survival in chemotherapy-naïve patients with metastatic colorectal cancer. Sleep Medicine. 2015;16(3):391-398. https://doi.org/10.1016/j.sleep.2014.10.022
  13. Irwin MR, Olmstead R, Carroll JE. Sleep disturbance, sleep duration, and inflammation: A systematic review and meta-analysis of cohort studies and experimental sleep deprivation. Biological Psychiatry. 2016;80(1):40-52. https://doi.org/10.1016/j.biopsych.2015.05.014
  14. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer. 2014;136(5):E359-E386. https://doi.org/10.1002/ijc.29210
  15. Shin DW, Sunwoo S, Lee JK. Management of cancer survivors in Korea. Journal of the Korean Medical Association. 2015;58(3):216-226. https://doi.org/10.5124/jkma.2015.58.3.216
  16. Tofthagen C, McAllister RD, Visovsky C. Peripheral neuropathy caused by paclitaxel and docetaxel: An evaluation and comparison of symptoms. Journal of the Practitioner in Oncology. 2013;4(4):204-215.
  17. Health Insurance Review & Assessment Service. Evaluate the appropriateness of its stomach cancer. [Internet]. Gangwondo: Health Insurance Review & Assessment Service; 2017 [cited 2017 November 13]. Available from: https://www.hira.or.kr/dummy.do
  18. Postma TJ, Aaronson NK, Heimans JJ, Muller MJ, Hildebrand JG, Delattre JY, et al. The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: The QLQ-CIPN20. European Journal of Cancer. 2005;41(8):1135-1139. https://doi.org/10.1016/j.ejca.2005.02.012
  19. Kim JH, Choi KS, Kim TW, Hong YS. Quality of life in colorectal cancer patients with chemotherapy-induced peripheral neuropathy. Journal of Korean Oncology Nursing. 2011;11(3):254-262. https://doi.org/10.5388/jkon.2011.11.3.254
  20. Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The pittsburgh sleep quality index: A new instrument for psychiatric practice and research. Psychiatry Research. 1989;28(2):193-213. https://doi.org/10.1016/0165-1781(89)90047-4
  21. Jang HS, Choi EO. Factors influencing quality of sleep among patients with colorectal cancer receiving chemotherapy. Asian Oncology Nursing. 2016;16(2):103-111. https://doi.org/10.5388/aon.2016.16.2.103
  22. Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, et al. The functional assessment of cancer therapy (FACT) scale: Development and validation of the general measure. Journal of Clinical Oncology. 1993;11(3):570-579. https://doi.org/10.1200/JCO.1993.11.3.570
  23. Kim HM. Symptoms related to chemotherapy induced peripheral neuropathy. [master's thesis]. Daegu: Keimyung University; 2012. p. 1-34.
  24. Nishiura M, Tamura A, Nagai H, Matsushima E. Assessment of sleep disturbance in lung cancer patients: Relationship between sleep disturbance and pain, fatigue, quality of life, and psychological distress. Palliative and Supportive Care. 2015;13(3):575-581. https://doi.org/10.1017/S1478951513001119
  25. Hallworth P, Simpson S, Bennett B, Byrne K, Rider A, Desai T, et al. PCN243-are there differences in Fact-G scores between different tumour types for an EU population using real world data?. Value in Health. 2017;20(9):A456. https://doi.org/10.1016/j.jval.2017.08.325
  26. Seo JY, Yi M. Distress and quality of life in cancer patients receiving chemotherapy. Asian Oncology Nursing. 2015;15(1):18-27. https://doi.org/10.5388/aon.2015.15.1.18
  27. Yu R, Deochand C, Krotow A, Leao R, Tong M, Agarwal AR, et al. Tobacco smoke-induced brain white matter myelin dysfunction: Potential co-factor role of smoking in neurodegeneration. Journal of Alzheimer's Disease. 2016;50(1):133-148. https://doi.org/10.3233/JAD-150751
  28. Oh SY, Shin SW, Koh SJ, Bae SB, Chang H, Kim JH, et al. Multicenter, cross-sectional observational study of the impact of neuropathic pain on quality of life in cancer patients. Supportive Care in Cancer. 2017;25(12):3759-3767. https://doi.org/10.1007/s00520-017-3806-5
  29. Lee JS, Jeong DU. Sleep and pain. Sleep Medicine and Psychophysiology. 2012;19(2):63-67.
  30. Jeong JH, Nho JH, Kim GS, Lee YE, Yu SY, Lee HJ, et al. Characteristics and quality of life in gynecologic cancer patients with chemotherapy-induced peripheral neuropathy. Journal of Korean Academy of Women's Health Nursing. 2013;19(4):201-210. https://doi.org/10.4069/kjwhn.2013.19.4.201